Autophagosome vaccine (UbiVac)

N/A

Report date: 2024/02/01 14:15:16
First In Class

Base Information

Drug NameAutophagosome vaccine (UbiVac)
Drug Alias NameDRibblesDRibble VaccineCancer vaccine DRibbleDPV-001
ClassificationVaccines > Application > Therapeutic vaccine
Mechanisms of ActionImmunostimulantsToll-like receptor agonists
TargetsToll-like receptor
Therapy Area/IndicationsProstatic NeoplasmsCarcinoma, Non-Small-Cell LungBreast Neoplasms +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusIND
Highest Status in ChinaIND
Originator CompaniesUbivac
China Registration ClassN/A

Develop Information

Active CompaniesConway (Guangzhou) Biotechnology Co Ltd
Inactive CompaniesUbivac
Active IndicationsCarcinoma, Non-Small-Cell LungBreast NeoplasmsSquamous Cell Carcinoma of Head and Neck
Inactive IndicationsProstatic Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A